Skip to main content
Learn More About Proton Therapy
Learn More About Proton Therapy
 

About Mevion

Mevion Medical Systems exists to deliver on the promise of proton therapy for cancer centers, clinicians and patients worldwide. We invented compact proton therapy and are continuing to transform the industry and patient care with the MEVION S250 Series™.

As a testament to the proven results delivered by our systems, we have more systems installed and treating patients than any other compact proton therapy manufacturer.

Powerful Medicine. Smart Business.

The MEVION S250 Series integrates our patented technology at the very forefront of proton therapy to deliver exceptional beam quality, industry-leading uptime, reduced system size and complexity, higher reliability and throughput, and lower capital and operating costs. Because of these advantages, more NCI-Designated Cancer Centers choose Mevion than any other proton therapy system provider.

The Mevion advantage is clear:

  • Superior clinical performance
  • Highly efficient design
  • Lower cost and rapid deployment
  • Proven profitability

Leadership Team

  • Lawrence Yuan Tian, Ph.D.

    Chairman

    Lawrence Yuan Tian, Ph.D.

    Chairman

    Mevion has benefited from Dr. Lawrence Tian’s leadership as a member of the board of directors since 2015 and was appointed Chairman in 2018. Dr. Tian brings a wealth of experience from the life sciences and medical device industry to this role. He is a Founding Partner of YuanMing Capital, a leading private equity firm which focuses on the investment in pharmaceutical research and development, innovative medical devices and high-end medical services in both China and the United States. He also serves as the Chairman of Investment Committee of China Pharmaceutical Industry Research and Development Association, and he is a member of the Biotech Advisory Panel of the Stock Exchange of Hong Kong Limited.

    Dr. Tian also brings experience networking business leaders to the Mevion leadership team. He is the founder and Chairman of the China Entrepreneurs Forum, the most influential business owners association in China, and is the founder of the China-U.S. Business Leaders Roundtable, a prestigious cross-border communication platform.

    Prior to Mevion, Dr. Tian has had successful career as a serial entrepreneur with a strong track record of success. In the financial markets, he founded China International Futures Co., Ltd. (CIFCO) in 1992. CIFCO grew into a leading brokerage firm and achieved the largest market share in China during his chairmanship. He also co-founded Wumart Group in 1994, which is currently the largest supermarket chain in Northern China.

    Dr. Tian obtained his master’s degree and doctoral degree from Wuhan University. He received the China Economics Theory Innovation Award, China’s highest prize for economics. 

  • Tina Tianning Yu, Ph.D.

    Chief Executive Officer

    Tina Tianning Yu, Ph.D.

    Chief Executive Officer

    Mevion’s Chief Executive Officer, Dr. Tina Yu, brings more than fifteen years of professional experience working in the life sciences sector and the financing world of the healthcare industry. As a Co-Founding Partner of YuanMing Capital, a healthcare fund focusing on cross-border investment strategies, Dr. Yu led the investment in BeiGene, Ascentage Pharmaceuticals, and Mevion Medical Systems. Prior to that, Dr. Yu worked for Vision Capital, an NYC-based investment management firm, as a Director of Investment, responsible for US biotech and China sectors. Before becoming an investor, Dr. Yu was a senior research scientist at Wyeth BioPharma, where she specialized in therapeutic protein development. She also worked for Fidelity, Morgan Stanley, and Genzyme. Dr. Yu founded Matching Capital Partners to provide cross-border consulting services in the life sciences industry.

    Dr. Yu holds a Ph.D. in Chemistry from Princeton University, an MBA from Harvard Business School, and a B.S. in Biology from the University of Science and Technology of China.

  • James Meng, Ph.D.

    President

    James Meng, Ph.D.

    President

    James Meng brings in 22 years of healthcare industry experience to Mevion. Dr. Meng’s professional and executive experiences include the management positions with Siemens Healthineers, Philips Healthcare and GE Healthcare. In these roles, he had the responsibilities for developing emerging medical technologies, creating the luminary segment, achieving market leadership position and exceeding the sales target. Most recently, James was the Chief Marketing Officer and the President of Alltech Medical Systems, a Chinese healthcare company.

    Dr. Meng holds a Ph.D. from the Nuclear Engineering Department of Massachusetts Institute of Technology, and Harvard/MIT Radiological Science and Technology Program, an MS from Nuclear Physics of University of New Hampshire and a BS from Nuclear Physics from University of Science and Technology of China.

Careers

Visit the Mevion career portal for a list of open opportunities.

ADP Recruitment